Back to search

Article

Delayed administration of recombinant plasma gelsolin improves survival in a murine model of severe influenza

2020-02-21

Abstract excerpt

<h4>Background: </h4> Host-derived inflammatory responses contribute to the morbidity and mortality of severe influenza, suggesting that immunomodulatory therapy may improve outcomes. The normally circulating protein, human plasma gelsolin, is available in recombinant form (rhu-pGSN) and has beneficial effects in a variety of pre-clinical models of inflammation and injury.   <h4>Methods: </h4>: We evaluated delay...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
ee164e03-dd4e-5e7e-ae8a-d28dd5610e96
DOI
10.12688/f1000research.21082.2
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 8 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Delayed administration of recombinant plasma gelsolin improves survival in a murine model of severe influenzaDOI 10.12688/f1000research.21082.2
Select a neighboring publication to make it the new centre.